Differential diagnosis of urticaria and angioedema has been based on the phenotype as either acute or chronic depending on the duration of more than 6 to 8 weeks, respectively. Additional subdivisions include poorly defined terms such as idiopathic, spontaneous, or autoimmune. In this article, the author suggests that an increased understanding of the acquired and innate immune system and data from novel proteomic technology have blurred the lines between these categories of diagnosis. Specific molecular pathways and response to specific medications should be incorporated in classification and diagnosis schemes.
Keywords: Autoantigen; Autoimmune; HERV; Herpes; Metagenome; Microbiome omalizumab; Proteomics; Virokine.
Copyright © 2016 Elsevier Inc. All rights reserved.